Plasma fibrinopeptide A and beta-thromboglobulin in pre-eclampsia and pregnancy hypertension.
Increased plasma levels of beta-thromboglobulin (beta TG) and fibrinopeptide A (FPA), markers of platelet release and thrombin generation respectively, were measured in normal women, women taking oral contraceptives, normal pregnancy and pregnant women with hypertension or pre-eclampsia. No significant increases in beta TG or FPA were found in women taking oral contraceptives. Significantly increased concentrations of beta TG, but not FPA, were found in normal pregnant women in the second and third trimester of pregnancy when compared with non-pregnant age-matched controls. In eleven women with pregnancy hypertension and thirteen women with pre-eclampsia significantly elevated levels of both beta TG and FPA were found when compared with age, parity and gestation-matched pregnant controls. Although the mean value for both beta TG and FPA in the group with pre-eclampsia was higher than the group with pregnancy hypertension, the difference was not statistically significant. These findings provide additional evidence that pre-eclampsia and pregnancy hypertension are associated with activation of the coagulation system and the platelet release reaction.
D001609:Beta-Globulins / Q000096:biosynthesis*; D003276:Contraceptives, Oral; D005260:Female; D005340:Fibrinogen / Q000096:biosynthesis*; D005344:Fibrinopeptide A / Q000096:biosynthesis*; D006801:Humans; D006973:Hypertension / Q000097:blood*; D011225:Pre-Eclampsia / Q000097:blood*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000097:blood; D011249:Pregnancy Complications, Cardiovascular / Q000097:blood; D011261:Pregnancy Trimester, First; D011263:Pregnancy Trimester, Third; D001620:beta-Thromboglobulin / Q000096:biosynthesis*
D001609:Beta-Globulins; D003276:Contraceptives, Oral; D001620:beta-Thromboglobulin; D005344:Fibrinopeptide A; D005340:Fibrinogen